Stock IGC IGC PHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News IGC Pharma, Inc.

Equities

IGC

US45408X3089

Market Closed - Nyse
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
0.487 USD -2.60% Intraday chart for IGC Pharma, Inc. -0.49% +73.87%
May. 28 IGC Pharma Begins Patient Enrollment for Mid-Stage Trial of IGC-AD1 to Treat Alzheimer's-Related Agitation MT
May. 28 IGC Pharma, Inc. Announces Patient Enrollment At Neurostudies in Phase 2 Trial Investigating IGC-AD1 CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
IGC Pharma Announces Patient Enrollment at Neurostudies, Inc. in Phase 2 Trial Investigating IGC-AD1
AQ
IGC Pharma Begins Patient Enrollment for Mid-Stage Trial of IGC-AD1 to Treat Alzheimer's-Related Agitation
MT
IGC Pharma Announces Patient Enrollment at Neurostudies in Phase 2 Trial Investigating IGC-AD1
BU
IGC Pharma, Inc. Announces Patient Enrollment At Neurostudies in Phase 2 Trial Investigating IGC-AD1
CI
IGC Pharma to Attend BIO International Convention 2024
BU
6.7 Million Americans Live With Alzheimer’s – IGC Pharma Believes They Deserve Treatment Options Without Black Box Warnings
AQ
IGC PHARMA : Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer’s Agitation
PU
IGC-AD1'S Interim Phase 2 Data Show a Reduction in Alzheimer's Agitation at Week Two
AQ
IGC-AD1’s Interim Phase 2 Data Show a Reduction in Alzheimer’s Agitation at Week Two
BU
IGC Pharma, Inc Announces Interim Data from Its Phase 2 Clinical Trial Demonstrates Clinically Significant Reduction, Approaching Statistical Significance, in Agitation in Alzheimer?S At Week Two Compared to Placebo
CI
IGC Pharma Adds Advisor in Artificial Intelligence
BU
IGC Pharma : Announces Positive Interim Results for IGC-AD1 in - Form 8-K
PU
IGC Pharma Announces $3 Million Unregistered Private Placement of its Common Stock
BU
Aurora, Canopy Among Cannabis Stocks Rising After Germany Passes Partial Legalization Law
MT
Aurora Cannabis, Canopy Growth Among Cannabis Stocks Rising After Germany Passes Partial Legalization Law
MT
IGC Pharma : Material Agreement - Form 8-K
PU
IGC Pharma, Inc. announced that it has received $3 million in funding from Bradbury Asset Management (Hong Kong) Limited
CI
IGC Pharma Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer's Agitation
AQ
IGC Pharma Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer’s Agitation
BU
IGC Pharma, Inc Announces the Results of an Interim Analysis of its Ongoing Phase 2 Trial Investigating IGC-Ad1 as Treatment for Agitation in Dementia from Alzheimer?s Disease
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IGC Stock
  4. News IGC Pharma, Inc.